Notice of Intent to Sole Source to Clarivate Analytics

The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to Clarivate Analytics for Metacore and Metadrug subscription license. Clarivate is the only vendor that offers the two components MetaCore and MetaDrug, for the tasks and projects related to the mechanism, metabolism, and biological predictions needed for our chemicals of concern, research projects, and customer support activities. The Government does not require installation and compliance with the organization guidelines, and other government organizations and partners also use these tools. We have worked and published with Clarivate on multiple projects. The government request to continue with the incumbent vendor for this service to maintain continuity of service and user-friendliness for authors, reviewers, associate editors, and staff accustomed to the Toxicology customized portal. Making a change would potentially harm our ability to publish crucial scientific research rapidly and could prove troublesome with regard

This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 41 U.S.C. 3304(a)(1).. Interested persons may identify their interest and capability to respond to the requirement or submit proposals.

This notice of intent is not a request for competitive quotations; however, all quotations/responses received within fifteen (15) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to Marva Lewis at knn5@cdc.gov by 4:00 pm EST on March 28, 2023